research

Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK-Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls.

Authors
Publication date
1 September 2016
Publisher
'Elsevier BV'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Repositório Aberto da Universidade do Porto

      redirect
      oaioai:repositorio-aberto.up.pt:1...
      Last time updated on 21/12/2017